Heart failure with reduced ejection fraction (HF-rEF) is responsible for high costs and increased rates of hospital admissions along with high mortality and morbidity risks. Only treatment for HF-rEF has been shown to be efficacious compared to HF-pEF which currently has no useful treatment options. Here is the latest research on HF-rEF.

January 9, 2021

Prediction of AF in Heart Failure With Preserved Ejection Fraction: Incremental Value of Left Atrial Strain

JACC. Cardiovascular Imaging
Ewelina Jasic-SzpakWojciech Kosmala
January 14, 2021

First in human experience with an epicardial beating heart device for secondary mitral regurgitation

The Journal of Thoracic and Cardiovascular Surgery
Vinod H ThouraniMichael J Mack
January 13, 2021
Open Access

Characterisation of the patients with suspected heart failure: experience from the SHEAF registry

Open Heart
Pankaj GargAbdallah Al-Mohammad
January 13, 2021
Open Access

Treatment of Heart Failure with Mid-Range Ejection Fraction: What Is the Evidence

Journal of Clinical Medicine
Eleni-Evangelia KoufouAndreas P Kalogeropoulos
January 8, 2021
Open Access

Partial anomalous pulmonary venous return after orthotopic heart transplantation case report

BMC Cardiovascular Disorders
Ismael A Salas de ArmasIgor D Gregoric
January 14, 2021

Trajectory of left ventricular ejection fraction among individuals eligible for implantable cardioverter-defibrillator

Pacing and Clinical Electrophysiology : PACE
Selma CarlsonSelçuk Adabag
January 10, 2021

Cine MRI detects elevated left heart pressure in pulmonary hypertension

Journal of Magnetic Resonance Imaging : JMRI
Kai LinJames C Carr
January 15, 2021

Echocardiographic estimation of left ventricular-arterial coupling in dogs with myxomatous mitral valve disease

Journal of Veterinary Internal Medicine
Tatsuyuki OsugaMitsuyoshi Takiguchi
January 10, 2021
Open Access

Genetic architecture of left ventricular noncompaction in adults

Human Genome Variation
Samantha Barratt RossChristopher Semsarian
January 9, 2021
Open Access

Conventional single-chamber pacemakers versus transcatheter pacing systems in a "real world" cohort of patients: A comparative prospective single-center study

Indian Pacing and Electrophysiology Journal
Jose Luis Martinez-SandeJose Ramon Gonzalez Juanatey
January 13, 2021


Ageing Research Reviews
Jacopo DemurtasNicola Veronese

Sign up to follow this feed and discover related papers.

Related Feeds

22q11 Deletion Syndrome

22q11.2 deletion syndrome, also known as DiGeorge syndrome, is a congenital disorder caused as a result of a partial deletion of chromosome 22. Here is the latest research.

Alagille Syndrome

Alagille syndrome is a multi-system genetic disorder that can affect the liver, heart, and other parts of the body. It’s characterization includes heart problems, liver damage, jaundice, and xanthomas. Here is the latest research.


Aneurysms are outward distensions or bulges that occurs in a weakened wall of blood vessels. Discover the latest research on aneurysms here.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.

Aortic Aneurysm

An aortic aneurysm is the weakening and bulging of the blood vessel wall in the aorta. This causes dilatation of the aorta, which is usually asymptomatic but carries the risk of rupture and hemorrhage. Find the latest research on aortic aneurysms here.

Aortic Coarctation

Aortic coarctation is a congenital condition characterized by narrowing of the aorta. Discover the latest research on this disease here.

ApoE Phenotypes

Apolipoprotein E (APOE) is a protein involved in fat metabolism and associated with the pathogenesis of Alzheimer's disease and cardiovascular disease. Here is the latest research on APOE phenotypes.


Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Arrhythmogenic Right Ventricular Dysplasia

Arrhythmogenic right ventricular dysplasia is a congenital cardiomyopathy that is characterized by infiltration of adipose and fibrous tissue into the right ventricle wall and loss of myocardial cells. Primary injuries usually are at the free wall of the right ventricular and right atria resulting in ventricular and supraventricular arrhythmias. Discover the latest research on arrhythmogenic right ventricular dysplasia here.

Arterial-Venous in Development & Disease

Arterial-venous development may play a crucial role in cardiovascular diseases. Here is the latest research.

© 2021 Meta ULC. All rights reserved